Total: 16 publication(s)


Zacherl S, La Venuta G, Müller HM, Wegehingel S, Dimou E, Sehr P, Lewis JD, Erfle H, Pepperkok R, Nickel W. (2015)

A direct role for ATP1A1 in unconventional secretion of fibroblast growth factor 2.

J. Biol. Chem. 290(6):3654-3665. doi:10.1074/jbc.m114.590067
Europe PMC | doi


Zanier K, Stutz C, Kintscher S, Reinz E, Sehr P, Bulkescher J, Hoppe-Seyler K, Travé G, Hoppe-Seyler F. (2014)

The E6AP Binding Pocket of the HPV16 E6 Oncoprotein Provides a Docking Site for a Small Inhibitory Peptide Unrelated to E6AP, Indicating Druggability of E6.

PLoS ONE 9(11) doi:10.1371/journal.pone.0112514
Europe PMC | doi

Brown D, Müller M, Sehr P, Pawlita M, Seitz H, Rubio I, Antonello J, Radley D, Roberts C, Saah A. (2014)

Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruses types 16 and 18

Vaccine doi:10.1016/j.vaccine.2014.08.004
Europe PMC | doi

Toft L, Storgaard M, Müller M, Sehr P, Bonde J, Tolstrup M, Østergaard L, Søgaard OS. (2014)

Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial.

J. Infect. Dis. 209(8):1165-1173. doi:10.1093/infdis/jit657
Europe PMC | doi

Toft L, Tolstrup M, Müller M, Sehr P, Bonde J, Storgaard M, Ostergaard L, Søgaard OS. (2014)

Comparison of the immunogenicity of Cervarix(®) and Gardasil(®) human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33 and HPV-45 in HIV-infected adults.

Hum Vaccin Immunother 10(5):1147-1154. doi:10.4161/hv.27925
Europe PMC | doi


Alfieri C, Gambetta MC, Matos R, Glatt S, Sehr P, Fraterman S, Wilm M, Müller J, Müller CW. (2013)

Structural basis for targeting the chromatin repressor Sfmbt to Polycomb response elements.

Genes Dev. 27(21):2367-2379. doi:10.1101/gad.226621.113
Europe PMC | doi

Pautus S, Sehr P, Lewis J, Fortuné A, Wolkerstorfer A, Szolar O, Guilligay D, Lunardi T, Décout JL, Cusack S. (2013)

New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain

J. Med. Chem. 56(21):8915-8930. doi:10.1021/jm401369y
Europe PMC | doi

Sehr P, Rubio I, Seitz H, Putzker K, Ribeiro-Müller L, Pawlita M, Müller M. (2013)

High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses

PLoS ONE 8(10):e75677. doi:10.1371/journal.pone.0075677
Europe PMC | doi


Casanova CM, Sehr P, Putzker K, Hentze MW, Neumann B, Duncan KE, Thoma C. (2012)

Automated high-throughput RNAi screening in human cells combined with reporter mRNA transfection to identify novel regulators of translation

PLoS ONE 7(9):e45943. doi:10.1371/journal.pone.0045943
Europe PMC | doi

Nieto K, Weghofer M, Sehr P, Ritter M, Sedlmeier S, Karanam B, Seitz H, Müller M, Kellner M, Hörer M, Michaelis U, Roden RB, Gissmann L, Kleinschmidt JA. (2012)

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate

PLoS ONE 7(6):e39741. doi:10.1371/journal.pone.0039741
Europe PMC | doi


Simon B, Kirkpatrick JP, Eckhardt S, Reuter M, Rocha EA, Andrade-Navarro MA, Sehr P, Pillai RS, Carlomagno T. (2011)

Recognition of 2'-O-methylated 3'-end of piRNA by the PAZ domain of a Piwi protein

Structure 19(2):172-180. doi:10.1016/j.str.2010.11.015
Europe PMC | doi

Rubio I, Seitz H, Canali E, Sehr P, Bolchi A, Tommasino M, Ottonello S, Müller M. (2011)

The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies

Virology 409(2):348-359. doi:10.1016/j.virol.2010.10.017
Europe PMC | doi


Dymalla S, Scheffner M, Weber E, Sehr P, Lohrey C, Hoppe-Seyler F, Hoppe-Seyler K. (2009)

A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein

J. Mol. Med. 87(3):321-331. doi:10.1007/s00109-008-0432-1
Europe PMC | doi


Bartonova V, Igonet S, Sticht J, Glass B, Habermann A, Vaney MC, Sehr P, Lewis J, Rey FA, Kraüsslich HG. (2008)

Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein

J. Biol. Chem. 283(46):32024-32033. doi:10.1074/jbc.m804230200
Europe PMC | doi

Guilligay D, Tarendeau F, Resa-Infante P, Coloma R, Crepin T, Sehr P, Lewis J, Ruigrok RW, Ortin J, Hart DJ, Cusack S. (2008)

The structural basis for cap binding by influenza virus polymerase subunit PB2

Nat. Struct. Mol. Biol. 15(5):500-506. doi:10.1038/nsmb.1421
Europe PMC | doi


Sehr P, Pawlita M, Lewis J. (2007)

Evaluation of different glutathione S-transferase-tagged protein captures for screening E6/E6AP interaction inhibitors using AlphaScreen

J Biomol Screen 12(4):560-567. doi:10.1177/1087057107301246
Europe PMC | doi